Restricted accessLetterFirst published online 2022-03
Re: “Clinical Recommendations for High Altitude Exposure of Individuals with Pre-Existing Cardiovascular Conditions: A Joint Statement by the European Society of Cardiology,the Council on Hypertension of the European Society of Cardiology,the European Society of Hypertension,the International Society of Mountain Medicine,the Italian Society of Hypertension and the Italian Society of Mountain Medicine” by Parati et al.
CoetzeeJH, HattinghJ, and MitchellD. (1982). Effects of heat and cold exposure and exercise on the interstitial fluid proteins of the rat. Comp Biochem Physiol A Comp Physiol, 72:437–440.
2.
CumpsteyAF, ClarkAD, SantoliniJ, JacksonAA, and FeelischM. (2021). COVID-19: A redox disease-what a stress pandemic can teach us about resilience and what we may learn from the reactive species interactome about its treatment. Antioxid Redox Signal, 35:1226–1268.
3.
GeldenhuysS, HartPH, EndersbyR, JacobyP, FeelischM, WellerRB, MatthewsV, and GormanS. (2014). Ultraviolet radiation suppresses obesity and symptoms of metabolic syndrome independently of vitamin D in mice fed a high-fat diet. Diabetes, 63:3759–3769.
4.
HillNE, DeightonK, MatuJ, MisraS, OliverNS, NewmanC, MellorA, O'HaraJ, and WoodsD. (2018). Continuous glucose monitoring at high altitude-effects on glucose homeostasis. Med Sci Sports Exerc, 50:1679–1686.
5.
KoufakisT, KarrasSN, MustafaOG, ZebekakisP, and KotsaK. (2019). The effects of high altitude on glucose homeostasis, metabolic control, and other diabetes-related parameters: From animal studies to real life. High Alt Med Biol, 20:1–11.
6.
MustafaOG, PenderS, MartinV, HaleS, EmmsR, BrookesP, BlanckenbergH, and ClaaseA. (2015). The use of safety checklists during a climbing challenge up Mount Kilimanjaro with 19 participants with type 1 diabetes. Presented at Diabetes UK Annual Professional Conference 2015. Diabet Med, 32:200.
7.
ObergD and OstensonCG. (2005). Performance of glucose dehydrogenase-and glucose oxidase-based blood glucose meters at high altitude and low temperature. Diabetes Care, 28:1261.
8.
ParatiG, AgostoniP, BasnyatB, BiloG, BruggerH, CocaA, FestiL, GiardiniG, LironcurtiA, LuksAM, MaggioriniM, ModestiPA, SwensonER, WilliamsB, BärtschP, and TorlascoC. (2018). Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: A joint statement by the European Society of Cardiology, the Council on Hypertension of the European Society of Cardiology, the European Society of Hypertension, the International Society of Mountain Medicine, the Italian Society of Hypertension and the Italian Society of Mountain Medicine. Eur Heart J, 39:1546–1554.
9.
PavanP, SartoP, MerloL, CasaraD, PonchiaA, BiasinR, NoventaD, and AvogaroA. (2003). Extreme altitude mountaineering and type 1 diabetes: The Cho Oyu alpinisti in Alta Quota expedition. Diabetes Care, 26:3196–3197.
10.
SiervoM, RileyHL, FernandezBO, LeckstromCA, MartinDS, MitchellK, LevettDZ, MontgomeryHE, MythenMG, GrocottMP, and Feelisch M; Caudwell Xtreme Everest ResearchGroup. (2014). Effects of prolonged exposure to hypobaric hypoxia on oxidative stress, inflammation and gluco-insular regulation: The not-so-sweet price for good regulation. PLoS One, 9:e94915.
11.
WestJB. (1984). Human physiology at extreme altitudes on Mount Everest. Science, 223:784–788.
12.
WoolcottOO, AderM, and BergmanRN. (2015). Glucose homeostasis during short-term and prolonged exposure to high altitudes. Endocr Rev, 36:149–173.
13.
YuB, LiC, SunY, and WangDW. (2021). Insulin treatment is associated with increased mortality in patients with COVID-19 and type 2 diabetes. Cell Metab, 33:65–77.